Patient Registry Study of Berinert® in Normal Clinical Practice

CompletedOBSERVATIONAL
Enrollment

318

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Includes: Hereditary Angioedema
Interventions
BIOLOGICAL

Berinert® (C1 Esterase Inhibitor)

Berinert® is marketed as a lyophilized concentrate available in a single-use vial to be reconstituted with sterile water before administration as described in the prescribing information.

Trial Locations (40)

5000

Denmark, Odense C, Odense C

10029

United States, New York, New York

10117

Germany, Berlin, Berlin

13212

United States, New York, North Syracuse

15213

United States, Pennsylvania, Pittsburgh

16601

United States, Pennsylvania, Altoona

17033

United States, Pennsylvania, Hershey

20815

United States, Maryland, Chevy Chase

21044

United States, Maryland, Columbia

27710

United States, North Carolina, Durham

29203

United States, South Carolina, Columbia

30342

United States, Georgia, Atlanta

45267

United States, Ohio, Cincinnati

45458

United States, Ohio, Centerville

55101

Germany, Mainz, Mainz

55446

United States, Minnesota, Plymouth

57702

United States, South Dakota, Rapid City

60596

Germany, Frankfurt, Frankfurt

63110

United States, Missouri, St Louis

64108

United States, Missouri, Kansas City

70118

United States, Louisiana, New Orleans

73131

United States, Oklahoma, Oklahoma City

74133

United States, Oklahoma, Tulsa

75231

United States, Texas, Dallas

81675

Germany, München, München

83404

United States, Idaho, Idaho Falls

85251

United States, Arizona, Scottsdale

88220

United States, New Jersey, Edison

90095

United States, California, Los Angeles

91344

United States, California, Granada Hills

92093

United States, California, San Diego

96003

United States, California, Redding

97035

United States, Oregon, Lake Oswego

98405

United States, Washington, Tacoma

99204

United States, Washington, Spokane

02115

United States, Massachusetts, Boston

08876

United States, New Jersey, Branchburg

08830

United States, New Jersey, Iselin

07712

United States, New Jersey, Ocean City

CH-6000

Switzerland, Luzern 16, Lucerne

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Chiltern International Inc.

INDUSTRY

lead

CSL Behring

INDUSTRY